ABBVIE

ABBVIE

Displaying 10 out of 10 results

  1. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the N

    AbbVie boosts 2019 profit outlook as Humira helps beat revenue estimates

    AbbVie Inc posted quarterly sales above estimates on Friday and raised the lower end of its 2019 profit forecast, helped by strong demand for ...
  2. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie terminates late-stage lung cancer trial

    AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed ...
  3. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's biosimilar to AbbVie's Humira wins FDA approval

    The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the ...
  4. AbbVie

    US biopharma AbbVie to buy Botox maker Allergan for US$63b

  5. FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore

    AbbVie looks beyond Humira with US$63 billion deal for Botox-maker Allergan

    AbbVie Inc is nearing a deal to buy Botox-maker Allergan PLC for more than US$60 billion, the Wall Street Journal reported on Tuesday, citing ...
  6. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie halts enrollment after brain cancer trial misses goal, shares fall

    AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to ...
  7. FILE PHOTO:  A trader works by the post that trades AbbVie on the floor of the New York Stock Excha

    AbbVie's Skyrizi drug to treat psoriasis wins US approval

    AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when ...
  8. New Content Item

    FDA puts partial hold on clinical trials of AbbVie's cancer drug

  9. A trader works by the post that trades AbbVie on the floor of the New York Stock Exchange

    Abbvie to record US$4 billion impairment charges on Stemcentrx assets

    Abbvie Inc on Friday said https://bit.ly/2F9iUlb it will record an estimated US$4 billion in impairment charges related to the scrapping of its ...
  10. Abbvie biologics facility launch

    AbbVie opens new biologics manufacturing facility in Tuas

    With the opening of the new facility, AbbVie’s manufacturing plant in Singapore will have created about 250 jobs. Moving forward, the US ...